In the BioHarmony Drug Report Database
Enoxaparin
Lovenox (enoxaparin sodium) is an oligosaccharide pharmaceutical. Enoxaparin sodium was first approved as Lovenox on 1993-03-29. It is used to treat myocardial infarction, postoperative complications, pulmonary embolism, thromboembolism, and thrombophlebitis amongst others in the USA. It has been approved in Europe to treat venous thromboembolism. The pharmaceutical is active against antithrombin-III.
Trade Name
|
Lovenox |
|---|---|
Common Name
|
enoxaparin sodium |
ChEMBL ID
|
CHEMBL1201476 |
Indication
|
myocardial infarction, postoperative complications, pulmonary embolism, thromboembolism, thrombophlebitis, unstable angina, venous thromboembolism |
Drug Class
|
Heparin derivatives and low molecular weight (or depolymerized) heparins |
Image (chem structure or protein)
